rs701320

Variant summary

Our verdict is Benign. The variant received -18 ACMG points: 0P and 18B. BP4_ModerateBP6_Very_StrongBA1

The NM_006080.3(SEMA3A):​c.1653-6C>T variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.788 in 1,552,192 control chromosomes in the GnomAD database, including 485,009 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.83 ( 52439 hom., cov: 31)
Exomes 𝑓: 0.78 ( 432570 hom. )

Consequence

SEMA3A
NM_006080.3 splice_region, intron

Scores

2
Splicing: ADA: 0.00007299
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 2.46

Publications

18 publications found
Variant links:
Genes affected
SEMA3A (HGNC:10723): (semaphorin 3A) This gene is a member of the semaphorin family and encodes a protein with an Ig-like C2-type (immunoglobulin-like) domain, a PSI domain and a Sema domain. This secreted protein can function as either a chemorepulsive agent, inhibiting axonal outgrowth, or as a chemoattractive agent, stimulating the growth of apical dendrites. In both cases, the protein is vital for normal neuronal pattern development. Increased expression of this protein is associated with schizophrenia and is seen in a variety of human tumor cell lines. Also, aberrant release of this protein is associated with the progression of Alzheimer's disease. [provided by RefSeq, Jul 2008]
SEMA3A Gene-Disease associations (from GenCC):
  • skeletal dysplasia
    Inheritance: AR Classification: DEFINITIVE Submitted by: G2P
  • hypogonadotropic hypogonadism 16 with or without anosmia
    Inheritance: AD Classification: STRONG, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • multiple congenital anomalies/dysmorphic syndrome
    Inheritance: AR Classification: MODERATE Submitted by: Ambry Genetics
  • Brugada syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Kallmann syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -18 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.37).
BP6
Variant 7-83977202-G-A is Benign according to our data. Variant chr7-83977202-G-A is described in ClinVar as Benign. ClinVar VariationId is 1174901.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.952 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SEMA3ANM_006080.3 linkc.1653-6C>T splice_region_variant, intron_variant Intron 14 of 16 ENST00000265362.9 NP_006071.1
SEMA3AXM_005250110.4 linkc.1653-6C>T splice_region_variant, intron_variant Intron 17 of 19 XP_005250167.1
SEMA3AXM_047419751.1 linkc.1653-6C>T splice_region_variant, intron_variant Intron 18 of 20 XP_047275707.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SEMA3AENST00000265362.9 linkc.1653-6C>T splice_region_variant, intron_variant Intron 14 of 16 1 NM_006080.3 ENSP00000265362.3
SEMA3AENST00000436949.5 linkc.1653-6C>T splice_region_variant, intron_variant Intron 15 of 17 5 ENSP00000415260.1

Frequencies

GnomAD3 genomes
AF:
0.825
AC:
125272
AN:
151856
Hom.:
52367
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.960
Gnomad AMI
AF:
0.775
Gnomad AMR
AF:
0.799
Gnomad ASJ
AF:
0.781
Gnomad EAS
AF:
0.887
Gnomad SAS
AF:
0.758
Gnomad FIN
AF:
0.672
Gnomad MID
AF:
0.741
Gnomad NFE
AF:
0.775
Gnomad OTH
AF:
0.827
GnomAD2 exomes
AF:
0.788
AC:
186776
AN:
236956
AF XY:
0.780
show subpopulations
Gnomad AFR exome
AF:
0.963
Gnomad AMR exome
AF:
0.826
Gnomad ASJ exome
AF:
0.782
Gnomad EAS exome
AF:
0.898
Gnomad FIN exome
AF:
0.669
Gnomad NFE exome
AF:
0.773
Gnomad OTH exome
AF:
0.779
GnomAD4 exome
AF:
0.784
AC:
1098096
AN:
1400220
Hom.:
432570
Cov.:
23
AF XY:
0.783
AC XY:
546392
AN XY:
697954
show subpopulations
African (AFR)
AF:
0.964
AC:
30572
AN:
31726
American (AMR)
AF:
0.828
AC:
34801
AN:
42048
Ashkenazi Jewish (ASJ)
AF:
0.779
AC:
19565
AN:
25128
East Asian (EAS)
AF:
0.890
AC:
33752
AN:
37938
South Asian (SAS)
AF:
0.742
AC:
58717
AN:
79178
European-Finnish (FIN)
AF:
0.675
AC:
35080
AN:
51960
Middle Eastern (MID)
AF:
0.723
AC:
4059
AN:
5612
European-Non Finnish (NFE)
AF:
0.782
AC:
835928
AN:
1068732
Other (OTH)
AF:
0.788
AC:
45622
AN:
57898
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.449
Heterozygous variant carriers
0
9778
19556
29334
39112
48890
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
19944
39888
59832
79776
99720
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.825
AC:
125406
AN:
151972
Hom.:
52439
Cov.:
31
AF XY:
0.817
AC XY:
60700
AN XY:
74278
show subpopulations
African (AFR)
AF:
0.960
AC:
39850
AN:
41512
American (AMR)
AF:
0.800
AC:
12214
AN:
15266
Ashkenazi Jewish (ASJ)
AF:
0.781
AC:
2710
AN:
3470
East Asian (EAS)
AF:
0.887
AC:
4575
AN:
5156
South Asian (SAS)
AF:
0.757
AC:
3653
AN:
4824
European-Finnish (FIN)
AF:
0.672
AC:
7058
AN:
10502
Middle Eastern (MID)
AF:
0.748
AC:
220
AN:
294
European-Non Finnish (NFE)
AF:
0.775
AC:
52670
AN:
67928
Other (OTH)
AF:
0.830
AC:
1751
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1066
2131
3197
4262
5328
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
876
1752
2628
3504
4380
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.789
Hom.:
155386
Bravo
AF:
0.843
Asia WGS
AF:
0.851
AC:
2957
AN:
3474

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Aug 09, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:2
-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.37
CADD
Benign
12
DANN
Benign
0.84
PhyloP100
2.5
Mutation Taster
=88/12
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.000073
dbscSNV1_RF
Benign
0.052
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs701320; hg19: chr7-83606518; API